Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Protocol of End-PSCI trial: a multicenter, randomized controlled trial to evaluate the effects of DL-3-n-butylphthalide on delayed-onset post stroke cognitive impairment

Fig. 1

Flow chart of End-PSCI trial. This is the flow chart of End-PSCI trial. Hospital patients with acute cerebral infarction (within 2 weeks of onset and with MRI evidences) will be randomized into either standard medical therapy group or standard medical therapy combined NBP treatment group. Cognitive function will be tested during the 24-week follow-up. MRI: magnetic resonance imaging, NBP: DL-3-n-butylphthalide

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us